These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 497395)

  • 1. Activated clotting factors in factor IX concentrates.
    Hultin MB
    Blood; 1979 Nov; 54(5):1028-38. PubMed ID: 497395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
    Hoffman M; Monroe DM; Oliver JA; Roberts HR
    Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays.
    Prowse CV; Chirnside A; Elton RA
    Thromb Haemost; 1980 Feb; 42(5):1355-67. PubMed ID: 6768149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of factor IX concentrate therapy in hemophilia.
    Hultin MB
    Blood; 1983 Sep; 62(3):677-84. PubMed ID: 6603880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human factor VII by activated factors IX and X.
    Masys DR; Bajaj SP; Rapaport SI
    Blood; 1982 Nov; 60(5):1143-50. PubMed ID: 7126868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet procoagulant complex assembly in a tissue factor-initiated system.
    Monroe DM; Roberts HR; Hoffman M
    Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.
    Samis JA; Kam E; Nesheim ME; Giles AR
    Blood; 1998 Aug; 92(4):1287-96. PubMed ID: 9694717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
    Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
    J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of factor X by factors IXa and VIII; a specific assay for factor IXa in the presence of thrombin-activated factor VIII.
    Hultin MB; Nemerson Y
    Blood; 1978 Nov; 52(5):928-40. PubMed ID: 698398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma.
    Morrison SA; Jesty J
    Blood; 1984 Jun; 63(6):1338-47. PubMed ID: 6722352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.
    Griffith MJ; Breitkreutz L; Trapp H; Briet E; Noyes CM; Lundblad RL; Roberts HR
    J Clin Invest; 1985 Jan; 75(1):4-10. PubMed ID: 3871202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between two concentrates with factor VIII inhibitor bypassing activity.
    Vinazzer H
    Thromb Res; 1982 Apr; 26(1):21-9. PubMed ID: 6980497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
    Mertens K; van Wijngaarden A; Bertina RM
    Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoaffinity purification of factor IX from commercial concentrates and infusion studies in animals.
    Smith KJ
    Blood; 1988 Oct; 72(4):1269-77. PubMed ID: 3262386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
    Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
    J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Bottasso B; Simoni L; Rosenberg RD
    Blood; 1990 Dec; 76(12):2540-5. PubMed ID: 2265248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Santagostino E; Tradati FC; Rosenberg RD
    Br J Haematol; 1991 Dec; 79(4):606-11. PubMed ID: 1772782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.